Selegiline - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for selegiline and what is the scope of patent protection?
Selegiline
is the generic ingredient in four branded drugs marketed by Somerset, Norvium Bioscience, Apotex, Lannett Co Inc, Novitium Pharma, Rising, Bausch, Apotex Inc, Chartwell Molecules, Cosette, Dash Pharms Natco, G And W Labs Inc, I3 Pharms, and Kenton, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.There are seventeen drug master file entries for selegiline. One supplier is listed for this compound.
Summary for selegiline
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 14 |
NDAs: | 17 |
Drug Master File Entries: | 17 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Clinical Trials: | 38 |
Patent Applications: | 7,807 |
Drug Prices: | Drug price trends for selegiline |
What excipients (inactive ingredients) are in selegiline? | selegiline excipients list |
DailyMed Link: | selegiline at DailyMed |
Recent Clinical Trials for selegiline
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Ibadan | Phase 1/Phase 2 |
E-Group ICT Software Informatikai Zrt. | Phase 2 |
László Mangel | Phase 2 |
Pharmacology for selegiline
Drug Class | Monoamine Oxidase Inhibitor Monoamine Oxidase Type B Inhibitor |
Mechanism of Action | Monoamine Oxidase Inhibitors Monoamine Oxidase-B Inhibitors |
Medical Subject Heading (MeSH) Categories for selegiline
Anatomical Therapeutic Chemical (ATC) Classes for selegiline
US Patents and Regulatory Information for selegiline
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cosette | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074756-001 | Nov 25, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
G And W Labs Inc | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074537-001 | Aug 2, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bausch | ZELAPAR | selegiline hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021479-001 | Jun 14, 2006 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Molecules | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074565-001 | Aug 2, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cosette | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074744-001 | Jan 27, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for selegiline
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-001 | Feb 27, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-001 | Feb 27, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-002 | Feb 27, 2006 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.